http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105017236-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac191130d34b9194ac000628600006cb |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
filingDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c808d03be8545c26cc0eb8890f8df65f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ddeb4949136193edc6cb8f29219b5ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e85e69471fa15f746a7748dba64dd3 |
publicationDate | 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105017236-A |
titleOfInvention | C-aryl glycoside derivatives, their pharmaceutical composition, preparation method and application |
abstract | The present invention relates to C-aryl glycoside derivatives, their pharmaceutical composition, preparation method and application. The preparation method includes: Method 1: in a solvent, under the action of a base, compound 1-f is subjected to a deacetylation protecting group reaction; method 2: 1. Compound 2-g is mixed with Carry out the Mitsunobu reaction; 2. The compound 2-f obtained in step 1 is subjected to a deacetylation protecting group reaction; method three: 1. Compound 3-g and Mix to carry out a nucleophilic substitution reaction; 2. The compound 3-f obtained in step 1 is subjected to a deacetylation protecting group reaction. The pharmaceutical composition comprises: C-aryl glycoside derivatives, pharmaceutically acceptable salts and/or prodrugs thereof, and auxiliary materials. The present invention also relates to the application of C-aryl glycoside derivatives, their pharmaceutically acceptable salts or pharmaceutical compositions in the preparation of SGLT inhibitors. The C-aryl glycoside derivatives of the invention provide a new direction for the research of SGLT inhibitors. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9914724-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112047915-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109988204-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112047915-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109988204-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106928040-A |
priorityDate | 2014-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.